Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion.
about
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusionAnti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusionBranch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalitiesIntravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis)Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series.The multifactorial nature of retinal vascular diseaseRetinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography.Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema.Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.Role of IL-6 in angiotensin II-induced retinal vascular inflammation.Vitreous inflammatory factors in macular edema with central retinal vein occlusion.Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results.Visual function and serous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series.Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control studyAn experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agentComparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.Changes of macular sensitivity and morphology after pars plana vitrectomy for macular edema with central retinal vein occlusion: a case seriesVisual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion.Influence of ischemia on visual function in patients with branch retinal vein occlusion and macular edema.Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panelPars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusionOutcomes of microincision vitrectomy surgery with internal limiting membrane peeling for macular edema secondary to branch retinal vein occlusion.Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.Vascular endothelial growth factor biology: clinical implications for ocular treatmentsEfficacy and safety of Pro Re Nata regimen without loading dose ranibizumab injections in retinal vein occlusion.Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment.Management of retinal vascular diseases: a patient-centric approach.Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case seriesA pharmacological approach in newly established retinal vein occlusion model.Foveal sensitivity and morphology in major and macular branch retinal vein occlusionPars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments.Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion.Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachmentCorrelation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion.Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion.The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases.Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
P2860
Q24201821-91EE4FAB-6D79-400B-A9C9-026D949205F6Q24234750-15684049-1DB4-4F57-B353-D94C2A33E9F8Q33320830-397B1E52-F823-4FCC-92CF-E66365DEFF79Q33416826-A0E4DF2A-306F-4AC7-9F4B-85CB5EC957B0Q33568145-3987CCBF-52BE-47B6-89F2-156C8F02EEB0Q33660130-AE63C5DF-5479-467B-8DD2-D54F5B954D11Q33760595-AA4FF0C7-9A8D-45C4-AA54-CC7C41A29265Q33770558-8C4DB039-4775-4B76-A59A-02527FC47132Q33795017-6EB42A1C-E07C-4DBA-A546-02A68F73624BQ33805314-12D2B934-5CAF-4A70-AB15-C4430F0C05ECQ33806214-3859AA87-A637-4DC5-8A3D-07E5935B51A5Q33845139-C2028F5D-415F-4219-8971-19E28100068AQ33888116-474E7B91-22AD-4820-9300-344EB1F9F62EQ33959122-94C9A25B-06EA-4CDB-8B51-E0A36F96DA4FQ34029173-17CE594D-3536-4587-A48C-B505838A72E9Q34149323-C078832B-1C37-46FA-84F0-6FA8AE2B7762Q34285235-0A5378FF-C354-4DFE-A627-0AB934F05FBDQ34372914-F989FE64-301D-4713-80F1-DF0D146FE679Q34573893-D55B4602-7051-40E2-AC84-3BBEA0B2540EQ34616286-D2506DD8-BD28-465B-BD72-D97908BFA4AAQ35015872-7FD4526E-88AA-425D-AA07-632D4E5A2FF1Q35135745-80BA33FC-3F4D-4E2C-A8B2-5E7CAF8DF9B8Q35161887-3318A426-BCB8-4DEF-806A-29AB9CAA0218Q35168707-1A92C018-C81E-4C68-8C7E-C4AB2B2B2BA4Q35209724-2BADD71F-2940-469E-A890-734A26654CF1Q35762769-360C98C9-C65D-4411-83C9-D5075597324AQ35796682-0346BFCF-5A73-4A31-9AA9-6B06D753C313Q35902075-2835E32D-230D-4F31-A50B-4832A361CE17Q35909406-11605F33-09FA-4EB2-9DC1-E6539473325EQ36029573-F50692D1-2924-45DE-BB97-774915D113E0Q36294951-198295BA-96AD-4F08-A615-BF4DB21ECAE9Q36460747-68992379-6142-4963-8B62-91A5B6BABF5DQ36575261-E27A63FE-14C8-481C-8F10-EA772C6266A9Q36830566-4C0216BF-2E86-40F8-942F-4D35216483CEQ36951463-3F05FFEE-C0E8-486B-B7DE-74F280F45003Q36991630-602396D1-D428-4820-9DC8-3A93B7502183Q37038532-73F943A0-FD53-4365-9D9F-897834F8395EQ37170006-0A59E513-D430-40F7-BDB1-C78655F2548CQ38242801-39573456-BF34-4063-B11A-EE499519C96DQ38414123-D05E35A4-9516-4DD2-ACF5-9EA1A47AC47F
P2860
Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Intravitreal levels of vascula ...... branch retinal vein occlusion.
@en
Intravitreal levels of vascula ...... branch retinal vein occlusion.
@nl
type
label
Intravitreal levels of vascula ...... branch retinal vein occlusion.
@en
Intravitreal levels of vascula ...... branch retinal vein occlusion.
@nl
prefLabel
Intravitreal levels of vascula ...... branch retinal vein occlusion.
@en
Intravitreal levels of vascula ...... branch retinal vein occlusion.
@nl
P2093
P2860
P1476
Intravitreal levels of vascula ...... branch retinal vein occlusion.
@en
P2093
Atsushi Minamoto
Hideharu Funatsu
Hidetaka Noma
Hidetoshi Tsukamoto
Hidetoshi Yamashita
Hiromu K Mishima
Kensuke Nakano
P2860
P2888
P304
P356
10.1007/S00417-004-1087-4
P577
2005-08-13T00:00:00Z